For the year ending 2025-12-31, RLAY made $15,355K in revenue. -$274,755K in net income. Net profit margin of -1789.35%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 15,355 | |||
| Research and development expenses | 261,383 | |||
| General and administrative expenses | 56,710 | |||
| Total operating expenses | 318,093 | |||
| Loss from operations | -302,738 | |||
| Interest income | 27,035 | |||
| Other (expense) income | -776 | |||
| Total other income, net | 26,259 | |||
| Net loss | -276,479 | |||
| Unrealized holding gain (loss) | 1,724 | |||
| Total other comprehensive income (loss) | 1,724 | |||
| Total comprehensive loss | -274,755 | |||
| Basic EPS | -1.61 | |||
| Diluted EPS | -1.61 | |||
| Basic Average Shares | 171,586,558 | |||
Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY)